---
schema_version: "secwatch.filing_event.v1"
accession: "0001472375-26-000167"
form_type: "8-K"
ticker: "RGPX"
cik: "0001357878"
company_name: "REGENEREX PHARMA, INC."
filed_at: "2026-06-11T17:52:03+00:00"
generated_at: "2026-06-11T17:53:17.492364+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Regenerex sues former CFO Perry for alleged $55K overpayments, $37K overcharges, stock theft

## Summary
- Complaint filed June 5, 2026, in Smith County Chancery Court (Case No. 2026-CV-8813).
- Alleges former CFO Perry caused unauthorized payroll overpayments totaling ~$55,200 over six months.
- Perry's company Optimize Health overbilled $136,056; includes alleged 30% administrative fee of ~$37,285.
- Perry authorized 25,000 shares of common stock to a trust without board approval, then canceled.
- Company says Perry's conduct caused delayed Form 10-K filing and substantial audit/remediation costs.

## SEC filing metadata
- accession: 0001472375-26-000167
- form_type: 8-K
- ticker: RGPX
- cik: 0001357878
- company_name: REGENEREX PHARMA, INC.
- filed_at: 2026-06-11T17:52:03+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357878/000147237526000167/0001472375-26-000167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357878/000147237526000167/ixform8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001472375-26-000167
- JSON: https://secwatch.observer/filing/0001472375-26-000167.json
- Plain text: https://secwatch.observer/filing/0001472375-26-000167.txt

## Key facts
- Executive change
  Kenneth W. Perry departed as Chief Financial Officer at REGENEREX PHARMA, INC..
  - Role: Chief Financial Officer
  source text: As of June 5, 2026, the Company has commenced legal proceedings against its former Chief Financial Officer, Kenneth W. Perry (the "Former CFO"), in the matter of Regenerex Pharma, Inc. v. Kenneth W. Perry , Smith County Chancery Court, Case No. 2026-CV-8813.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237526000167/0001472375-26-000167-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.